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Background: Health professionals strive to deliver high-quality care in an inherently complex and error-prone
environment. Underreporting of medical errors challenges attempts to understand causative factors and impedes
efforts to implement preventive strategies. Audit with feedback is a knowledge translation strategy that has potential
to modify health professionals’ medical error reporting behaviour. However, evidence regarding which aspects of this
complex, multi-dimensional intervention work best is lacking. The aims of the Safe Medication Audit Reporting
Translation (SMART) study are to:
1. Implement and refine a reporting mechanism to feed audit data on medication errors back to nurses
2. Test the feedback reporting mechanism to determine its utility and effect
3. Identify characteristics of organisational context associated with error reporting in response to feedback
Methods/design: A quasi-experimental design, incorporating two pairs of matched wards at an acute care hospital, is
used. Randomisation occurs at the ward level; one ward from each pair is randomised to receive the intervention.
A key stakeholder reference group informs the design and delivery of the feedback intervention. Nurses on the
intervention wards receive the feedback intervention (feedback of analysed audit data) on a quarterly basis for
12 months. Data for the feedback intervention come from medication documentation point-prevalence audits
and weekly reports on routinely collected medication error data. Weekly reports on these data are obtained for
the control wards. A controlled interrupted time series analysis is used to evaluate the effect of the feedback
intervention. Self-report data are also collected from nurses on all four wards at baseline and at completion of
the intervention to elicit their perceptions of the work context. Additionally, following each feedback cycle, nurses
on the intervention wards are invited to complete a survey to evaluate the feedback and to establish their intentions
to change their reporting behaviour. To assess sustainability of the intervention, at 6 months following completion of
the intervention a point-prevalence chart audit is undertaken and a report of routinely collected medication errors for
the previous 6 months is obtained. This intervention will have wider application for delivery of feedback to promote
behaviour change for other areas of preventable error and adverse events.
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Health care is inherently complex and therefore error-
prone, and despite health professionals striving for high-
quality patient care, medical error and threats to patient
safety are ubiquitous [1]. Although estimates of the frequency
of medical errors and injuries vary considerably, even
the most conservative estimates indicate that the prob-
lem is widespread [2]. Significantly, preventable medical
errors are associated with immeasurable human costs
and substantial economic burden [3]. Widespread under-
reporting of medical errors [4–10] hampers efforts to ana-
lyse causative factors and hinders ability to systematically
target preventative strategies. One strategy to promote
reporting, audit with feedback, has the potential to modify
health professionals’ behaviour; however, limited evidence
exists regarding which aspects of this complex, multi-
dimensional intervention work best.
In this paper, we report a study protocol to refine and
test an audit with feedback intervention (the Safe Medica-
tion Audit Reporting Translation (SMART) intervention).
The intervention is aimed to inform decision-making and
motivate behaviour change among nurses in order to
maximise reporting of medication errors and ultimately
improve patient safety.
Use of audit to monitor performance and improve patient
safety
In health care, auditing practice is widely used to measure
performance and inform quality improvement initiatives.
Collection of audit data and routine reporting of adverse
events (AEs) provides evidence of performance in relation
to quality standards and use of research evidence. While
audit is necessary, used alone it is unlikely to be sufficient
to improve quality [11]. Audit data, however, can be fed
back to stimulate behaviour change [12, 13].
Feedback plays a key role in organisations, providing
employees with information about performance that meets
or fails to meet the expected standard [14]. However, feed-
back can have a positive or deleterious effect (such as pas-
sive resistance), dependent on how it is delivered [14]. This
highlights the importance of intervention design in order
to ensure that the feedback promotes and supports behav-
iour change to improve performance.
Evidence for audit with feedback
Evidence indicates that the effectiveness of audit with
feedback is likely to be greater when: baseline adherence
to the practice is low [12, 13]; health professionals actively
participate in the change process [12]; the feedback in-
cludes clear and specific goals and a strategy for achieving
them [15]; it is delivered in a timely manner in association
with the respective behaviour [16, 17]; the feedback is
delivered both verbally and in writing, and it is delivered
by a person in a position of seniority, rather than anunknown source [13]; and the feedback is delivered in
repeated cycles as opposed to a single episode [13].
Authors of a 2006 Cochrane review, and the updated
review in 2012, of evidence for effectiveness of audit
with feedback concluded that the intervention is one for
which we know little about how, when and why it is most
effective [12, 13]. However, authors of the updated review
concluded, “when optimally-designed and used in the
right context, [audit with feedback] can play an important
role in improving professional practice” ([13], p. 30). Ac-
cording to their findings, audit with feedback has potential
to result in a small but meaningful improvement in health
professionals’ behaviour [13]. Yet Foy et al. warn “… audit
and feedback will continue to be an unreliable approach
to quality improvement until we learn how and when it
works best” ([18], p. 50).
Feedback is not a simple stimulus, but rather a complex,
multi-dimensional intervention that is dependent on
characteristics of the organisational context, the indi-
vidual recipient, the message and the source of feedback
[14, 15, 19–21]. Identifying six dimensions that impact
on the form and intensity of feedback (recipient, format,
source, frequency, duration and content), Jamtvedt et al.
note that a lack of attention to different feedback inten-
sities is evident in published studies [12]. Additionally, the
literature provides limited description of feedback innova-
tions in terms of the process of development and design
characteristics [11, 12, 15]. Ivers and colleagues call for
components of future feedback interventions to be care-
fully described, including the theoretical justification [15].
The influence of contextual factors on the effectiveness
of feedback is also being increasingly recognised [22, 23]
but remains poorly understood. Hysong and colleagues
found that settings perceived as high performing were
more likely to rely on chart data for feedback and placed
greater emphasis on educational approaches to feedback
[24]. Evidence, however, for the means by which such an
intervention works in the context of complex healthcare
organisations is scarce [11].
The impact of medication errors upon quality and safety
in health care
Over a decade has elapsed since the Institute of Medicine
released their influential publication, To Err is Human
[25], in which they reported that between 44,000 and
98,000 deaths occur annually as a result of medical er-
rors. This report attracted international attention and
significantly raised the profile of patient safety in hospi-
tals and with health policy leaders [26].
While some progress has been made since publication
of To Err is Human [25], the Australian Commission on
Safety and Quality in Health Care estimates that medica-
tion administration errors occur in 5–10 % of all medicines
administered, signalling an immense safety and quality
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reportedly occur in 3–8 % of all hospital admissions [27],
while in the USA, medication errors have been estimated
to account for 7,000 deaths per year [25]. The Institute of
Medicine Committee on Identifying and Preventing Medi-
cation Errors estimates that at least 1.5 million prevent-
able adverse medication events occur annually in the
USA, warning that this is likely to significantly underesti-
mate the problem [28]. Other international research indi-
cates that medication administration errors are associated
with 5 % to 20 % of AEs [29], with 35.1 % of these being
preventable [2].Medication errors are underreported
The international literature laments the dearth of reliable
statistics globally regarding medication error rates. The
aforementioned medication error rates are just the tip of
the iceberg according to the Institute for Safe Medication
Practices (ISMP) in the USA [30]. This is further corrobo-
rated by literature in this area, with estimates of medica-
tion error reporting rates ranging from 25 % to 70 % of all
medication errors [8, 9, 31]. Researchers found that 34.8 %
of nurses and physicians reported less than 20 % of per-
ceived errors within the previous 12 months [10].
While reporting of such events is essential for promotion
of a safety culture and to inform strategies to increase
safety, there are numerous reasons for underreporting, in-
cluding a perception that if no harm is caused, the error is
not worthy of reporting [32, 33]. Lack of feedback has also
been cited as one of the most common reasons for failure
to report medication errors [34]. However, system modifi-
cations, feedback and education are unlikely to lead to sig-
nificant improvements in reducing errors if the information
surrounding errors is misleading or incomplete. It is well
recognised that significant underreporting masks the true
incidence of the problem and the circumstances surround-
ing errors, seriously hampering efforts to identify potential
solutions and strategically target preventative strategies.
Medication therapy is the most common medical treat-
ment received by patients, and medication administration
is a routine part of nursing practice. Errors in medication
administration expose patients to preventable harm [35].
The human costs related to medication errors encumber
those who are harmed, their families and friends, as well
as the health professionals who care for them. Thus there
are ethical, humanitarian and financial imperatives to ex-
pose the extent and aetiology of medication errors and
AEs and implement strategies to improve detection, man-
agement and prevention [3]. Evidence suggests that up to
80 % of medical errors are the result of system defects
[36]. Thus, reporting of medication errors is fundamental
to quality improvement efforts and redesign initiatives to
promote safety in health care.This study is designed to fill gaps identified in existing
research in this field, specifically by exploring how, when
and in what context feedback works best to influence
medication error reporting behaviour among nurses. The
findings of this study will add to knowledge about charac-
teristics, including the content and intensity (dose) of audit
and feedback that are important in influencing health pro-
fessionals’ behaviour regarding reporting of medication er-
rors. Measurement of health professionals’ perceptions of
organisational context will enable us to assess the extent to
which contexts perceived as more favourable are associated
with increased reporting of errors.
Aim, purpose and study objectives
This study aims to refine and test an audit with feedback
knowledge translation intervention (SMART) in order to
promote nurse reporting of medication-related errors in
clinical practice and add to the evidence base regarding
nurses’ response to audit with feedback. The clinical pur-
pose of the intervention is to increase reporting and ac-
curacy of medication error data so that targeted strategies
may be developed to reduce their incidence in the future.
In order to achieve this, the specific aims are:
1. To implement and refine a reporting mechanism to
feed audit data on medication errors back to inpatient
nurses
2. To test the feedback reporting mechanism to
determine its utility (including understandability,
usability, usefulness and effectiveness in increasing
medication error reporting)
3. To identify characteristics of organisational context
associated with error reporting in response to feedback
Theoretical framework
This study is informed by two complementary theoret-
ical approaches. The Promoting Action on Research Im-
plementation in Health Services (PARIHS) framework
focuses on the relationship between three key elements
(evidence, facilitation and context) in influencing the
implementation of research in practice [37, 38]. This
framework, however, has limited applicability in studying
the influence of individual characteristics on behaviour
change. For this reason, the Theory of Planned Behaviour
(TPB), which helps explain an individual’s intent to change
their behaviour, also informs this study.
PARIHS
The PARIHS framework was developed by Kitson et al.
to help explain the reasons for success or failure of
implementation projects [39]. For the purposes of this
study, evidence relates to data on medication error and
reporting rates, context constitutes the ward environment
(i.e., culture, leadership and evaluation/feedback processes)
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tion denotes roles and strategies to promote the behaviour
change.
TPB
The TPB is an extension of the Theory of Reasoned Ac-
tion [40], according to which behavioural intention is the
precursor to actual behaviour and intentions are formed
based on information or beliefs that a certain behaviour
will lead to a particular outcome [41]. Subjective norms,
the perceived social pressure to comply with a behaviour,
can determine whether or not an individual performs the
behaviour [42].
The TPB extends on the Theory of Reasoned Action
to include individuals’ perceptions of behavioural control
[43]. Perceived behavioural control, perception of the ease
or difficulty of performing the behaviour, is thought to
influence both behaviour and intent [43]. Inclusion of
perceived behavioural control expands understanding
of the constraints on behaviour and acknowledges that
intentions do not always predict behaviour [43]. This is
relevant to medication error reporting behaviour in that
intent to report errors may be influenced by other fac-
tors that ultimately lead to non-reporting behaviour. It
is also important to determine if feedback affects behav-
ioural intent. Ajzen [42] suggests that these constructs
(beliefs, subjective norms and perceived behavioural con-
trol) will vary in their level of influence across settings and
behaviours; for example, in settings where individuals have
strong opinions and attitudes perceived behavioural con-
trol may be a less reliable predictor of intention [43]. A
meta-analysis of 161 studies using the TBP [43] supported
the use of this theory to predict intentions and behaviour.
Pilot testing an intervention to improve medication error
reporting
Consistent with the UK Medical Research Council guide-
lines for the development of complex interventions [44],
we conducted a small study in a 32-bed acute care ward at
a large private hospital to inform development and under-
take pilot and feasibility testing of medication chart audit
tools and the SMART feedback intervention.
Baseline audit data were collected on key aspects of
medication administration. At baseline, all ward nursing
staff were invited to complete the Alberta Context Tool
[45, 46], a questionnaire designed to elicit perceptions of
the work context (including culture, leadership and feed-
back mechanism). The feedback intervention comprised
Microsoft PowerPoint© presentations to display audit data
and survey results in graph form, coupled with face-to-
face discussions about the results. Additionally, copies of
the results slides were displayed on the ward for staff
to view. The feedback was augmented with information
about the definition of a medication error, the importanceof reporting medication errors and near misses and the
importance of a no-blame culture.
Medication administration audit data were collected
2 months following the feedback intervention, and staff
were re-surveyed about their perceptions of the work
context 6 months following collection of the baseline data.
The frequency of medication errors in the 12 months
prior to the intervention and in the 6 months post-
intervention was compared. We found an 80 % increase
in the reporting of medication errors and a statistically
significant improvement in perceptions of evaluation
and feedback mechanisms (including access to data, re-
view, monitoring and benchmarking). The considerable
increase in frequency of error reporting in the post-
intervention phase highlighted the potential for this
intervention to improve error reporting across the or-
ganisation and beyond and the importance of more
rigorous testing of the intervention.
This pilot work underpins the study that is the subject
of this protocol. The premise upon which this study is
built is that comprehensive reporting of medication er-
rors is necessary to inform interventions and process re-
design to prevent further errors occurring.
Methods
This controlled interrupted time series study design in-
corporates two pairs of matched wards at an acute care
hospital with randomisation of two wards to the control
group and two wards to the intervention group. Nurses
in the intervention group will receive the SMART inter-
vention (feedback of medication error audit data).
We will adopt the National Coordinating Council for
Medication Error Reporting and Prevention standard
definition of a medication error: “any preventable event
that may cause or lead to inappropriate medication use
or patient harm while the medication is in the control of
the health care professional, patient, or consumer” [47].
Setting and sample
This study will take place at a large, not-for-profit Australian
private health provider. Four acute care wards will be
included in the study. The wards will be matched as
closely as possible according to clinical casemix (diagnostic
group and average length of stay).
A key stakeholder reference group will be established
to determine the preferred feedback methods and mech-
anism (the design of the feedback report and how it is
presented to staff ). This group was instrumental to feed-
back design in the pilot study and will include clinical
nurses and representatives from nursing management,
pharmacy and medicine (n = 10).
Managers (n = 4) and nurses (n = 160) working in the
four participating wards will be invited to participate in
this study.
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Audit data sources
Two sources of audit data will be used in the feedback
report:
1) Medication error reports and medication adverse
event data that are routinely reported in the risk
management and reporting system (RiskMan.Net ©)
in the study organisation and
2) Data generated from point-prevalence audits of
medication documentation in patients’ medical
records.
Survey data sources
Two other sources of data are surveys of nurse participants:
1) The Alberta Context Tool (ACT) will be
administered twice to nurses in all four wards: at
baseline, prior to introduction of the feedback
reports and 12 months following baseline data
collection [45, 46].
2) The post-feedback survey will be administered four
times to intervention ward participants (1 week fol-
lowing each feedback report) [11].
Interview data sources
Following the final 2 cycles of feedback, focus group
interviews will be conducted with consenting nurses
working on the intervention wards.
Instruments
The ACT was developed, and tested for validity, for use
in acute care settings [45]. The ACT consists of a suite
of instruments designed to assess modifiable characteris-
tics of organisational context [48]. The tool consists of
56 items to assess eight dimensions of the work context:
culture, leadership, evaluation, social capital, informal in-
teractions, formal interactions, structural and electronic
resources, and organisational slack (representing time,
space and human resources).
The post-feedback survey was developed to elicit per-
ceptions about the use of feedback, including whether
the individual received the feedback report, whether they
reviewed it, whether and how they used it to inform
their practice, and barriers to using the report [11]. Add-
itionally, based on the Theory of Planned Behaviour, a
series of questions assess the individual’s intent to change
behaviour in response to the feedback, and if so, how [11].
The instrument also includes questions to assess the
utility of the report, including whether the feedback is
understandable and engaging, relevant to policy and
practice, presented in a form that can be used to inform
and influence practice, and whether the process of re-
port delivery is appropriately timed and the report isreadily accessible. Respondents are also invited to record
suggestions/recommendations to improve the feedback
reports.
The clinical chart audit tool developed for and used in
our pilot testing will be adapted for collection of the
point-prevalence data in the current study. Chart audit
data will be collected on all four wards, quarterly for the
12 months.
Focus group interviews will be undertaken using an inter-
view guide to elicit nurses’ perceptions and experiences in
receiving, reading, discussing, assimilating and using the
feedback reports to inform their actions.
Procedure
Baseline data collection
The Alberta Context Tool will be administered to all
nurses on all four wards prior to implementation of the
intervention. Point-prevalence audit data will be collected
at baseline in all four wards, and a report of medication
errors recorded for each ward for the previous 12 months
will be extracted from RiskMan.
Development of the SMART intervention
Audit data will be analysed and reported descriptively
(including frequencies by time of day, day of week, type
of medication, route of administration). Development
of the feedback report (including the presentation and
content) will be informed by recommendations and feed-
back from the key stakeholder reference group. Because
we will have a range of variables that could be reported
on, we will elicit from the key stakeholder group the prior-
ities for reporting of data.
The format adopted for presentation of medication
error report rates and medication AE rates will take into
consideration: content (which variables to report), frequency,
presentation (graphs, description) and supporting processes
(information sessions). In developing the feedback reports,
we will seek advice from the key stakeholder group re-
garding presentation of data, including promotion of
visual appeal (considering layout, use of white space,
colour, use of illustrations/figures), striving to make the
content understandable (clear and concise description
and illustrations that can be readily understood), and
ensuring that the content is relevant.
Testing the SMART intervention
Administration In conjunction with the key stakeholder
reference group, the timing and mechanism for delivery
of the feedback report will be determined. At a mutually
convenient time, the researcher will meet with the rele-
vant nurse unit managers of the two intervention wards
to explain the project and arrange a suitable time for
delivery of the feedback reports. A brief information
session will be conducted in conjunction with delivery
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mined by the nurse unit manager. Feedback reports will
be provided on a quarterly basis for 12 months. The “usual
care” wards will not receive the SMART intervention.Evaluation For 12 months, routinely reported RiskMan
data will be extracted weekly and point-prevalence chart
audits will be conducted quarterly on all four wards. On
the intervention wards, data will be collected to evaluate
the feedback reporting process and to elicit the opinions
of managers and nurses with respect to the understand-
ability, usefulness and usability of the report content.
The findings will inform modifications to the report for
future waves of report delivery.
On a quarterly basis, 1 week following delivery of the
feedback report, nurses will be invited to complete the
post-feedback survey, a brief, paper-based survey [11].
The researchers, in conjunction with the key stakeholder
reference group, will consider the findings of the survey
and modify future feedback reports accordingly. These
modifications will then be re-evaluated by survey. Thus,
a series of feedback reports, each containing the most
current medication error report rates (from the point-
prevalence medication chart audits) and medication-related
errors and AEs (from RiskMan data) will be produced and
each will be informed by survey data evaluating the previ-
ous reports. If and when the survey data no longer indicate
the need for future modifications, the feedback report will
not be modified and the staff will not be re-surveyed.
Completion of the survey will be voluntary, and return
of the survey will imply consent. Survey data will be
manually entered into an IBM SPSS Statistics [49] database
for analysis. Following the final 2 cycles of feedback, nurses
on the intervention wards will be invited to participate in a
focus group interview to discuss the process of using the
feedback.Process measures Process measures include self-reported
uptake of feedback reports (survey data), intent to changeFig. 1 Elements and stages of data collectionbehaviour (survey data) and perceptions of the feedback
report (survey data on report content, presentation; inter-
view data).Outcome measures Outcome measures include point-
prevalence audit data and medication error reports. While
we expect to observe an increase in medication error
reporting rate as a result of the intervention, at some
point, potentially as a culture of medication safety is de-
veloped, we may observe a decrease in medication error
reporting because the true rate of errors decreases.
Post-intervention data collection
Following the 12-month intervention period, the ACT
will be administered to all nurses on all four wards. Six
months following completion of the intervention phase
(18 months post-baseline data collection), a repeat point-
prevalence chart audit will be undertaken and a report of
reported medication errors and AEs for the previous
6 months will be extracted from RiskMan. These data will
be used to assess sustainability of the intervention. Fig. 1
illustrates the stages of the data collection.
Individual nurse participant involvement in the study
for intervention and control wards is illustrated in Fig. 2.
Analysis
Quantitative methods will be used to analyse the survey
data. Analysis will involve the use of simple descriptive
statistics, including frequencies and cross tabulations, and
bivariate analysis using correlations. Interrupted time
series analysis will be used to assess for change over time
in response to the feedback. Outcomes will include error
rates identified during the point-prevalence chart audits
and the error report rates identified from RiskMan data.
These data will be aggregated at ward level.
We will also examine RiskMan data for the 12-month
period prior to the intervention. Intervention dose will
be the main predictor, operationalised as the number of
nurses on the ward who self-report reading the feedback
Fig. 2 Nurse involvement in the study
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mensions of organisational context will also be included
as predictors of medication error reporting rates. Multi-
variate regression analyses will include cluster correction
to adjust for ward and site effect. Content analysis will be
used to analyse string variable responses to open-ended
questions about suggestions to improve reports. Qualita-
tive data will be analysed using content and thematic ana-
lysis techniques.
Ethical considerations
Operational approval for the study has been provided by
the Director of Nursing at the hospital. Ethics approval
has been obtained from the hospital’s Human Research
Ethics Committee and Deakin University. Prior to com-
mencement of the study, permission will be sought from
the Nurse Unit Managers of the selected wards in order
to access staff. This is a minimal risk study.
Expected outcomes
We expect that this knowledge translation feedback inter-
vention will result in improved quality and frequency of
reporting of medication errors. This will enable us to
understand the scale and nature of medication errors
occurring in the intervention units. Our intent is to pro-
duce a parsimonious, efficient and effective method of
providing feedback to health professionals about a quality-
related measure of practice. We anticipate that this project
will result in the development of a feedback approach that
can be adapted for and evaluated in other healthcaresettings and for additional areas of preventable adverse
events. Importantly, this study is designed to add to the
body of knowledge about how, when and in what con-
text feedback works best.
Strengths and limitations of study
This study will add to the evidence base on use of audit
with feedback among nurses. In particular, it will promote
understanding of the potential for feedback to promote
behaviour change regarding medication error reporting,
how and in what forms nurses prefer to receive feedback
and how the contexts in which nurses work affect their
ability to report medication errors. Additionally, the study
will contribute knowledge about the accuracy of medica-
tion error reporting, comparing hospital incident report-
ing system data with evidence of administration errors in
medical record documentation.
Limitations of this study need to be acknowledged.
The study is to be conducted at a single site, with a rela-
tively small sample. While we will match intervention
and control wards as closely as possible on the basis of
clinical casemix, there is no guarantee that matched wards
within the same hospital will be entirely similar (e.g.,
differences in ward culture, patient acuity/type, staffing
turnover); hence, we will adjust for differences using the
available data. Feedback will be constructed based upon
advice from the key stakeholder group. It is possible that
this format will not suit all nurses, and so, some staff may
not find the feedback meets their needs and may discount
it as a result. Behaviour change in reporting may also
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and/or serious medication incidents that make staff more
aware/anxious about reporting). Hence, not all behaviour
change may be attributable to the feedback intervention.
Potential for contamination of the control group exists;
however, the organisation has a stable nursing workforce
with a vacancy rate of less than 5 %. Thus, permanent staff
do not commonly work across different wards, thereby
limiting the risk of contamination.
Dissemination and spread
This study will add new knowledge that will be of par-
ticular interest and relevance to health professionals and
administrators. We will use a multi-faceted approach to
disseminate the findings of this study to health profes-
sionals, administrators and policy-makers. We will present
the results in journal articles and at local, national and
international healthcare conferences. We will also com-
municate the findings through our formal and informal
networks, nationally and internationally.
The partner organisation and members of the research
team are committed to sharing new knowledge to pro-
mote safe, high-quality care delivery. Our findings will
be disseminated through the collaboration’s existing net-
works, and a summary of the findings and information
on the study, in a plain language format, will also be posted
on the university website. Members of the research team
sit on a range of policy decision-making committees and
professional associations. As such, they have extensive
networks for wide dissemination of the study findings.
Study status
Data collection commenced in February 2015 and will
finish in 2016. The data collection cycle is illustrated in
Fig. 1.
Discussion
This study has the capacity to make a significant contri-
bution to the literature in terms of the efficacy of audit
with feedback for nurses. Factors affecting reporting of
medication errors will be clarified and will allow health-
care organisations to target quality programmes and feed-
back strategies to effect positive change. The theoretical
basis and methodological design of this study integrates
well-established theories and methods to comprehensively
address the research questions. This intervention will po-
tentially have wider application for the delivery of feed-
back to health professionals working in other settings, for
other areas of preventable adverse events and to promote
behaviour change in aspects of care such as use of clinical
practice guidelines. These findings will inform develop-
ment of future interventions, including system redesign,
to prevent medication errors. This research has potential
to inform initiatives to improve the quality and safety ofcare received by patients in the acute care setting and will
also have significance internationally in the field of know-
ledge translation.
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